Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective

GLP1 receptor agonists (GLP1-RAs) are drugs that mimic the effects of the incretin hormone GLP1 and were initially introduced in medicine for the treatment of diabetes in 2005 and for obesity in 2014. Over time, data from secondary and exploratory objectives of large randomized controlled-trials sug...

Full description

Autores:: Rico-Fontalvo, Jorge
Reina, Maricely
Soler, María José
Unigarro-Palacios, Mario
Castañeda González, Juan Pablo
Jiménez Quintero, Javier
Raad Sarabia, Maria Isabel
Proenca de Moraes, Thyago
Daza-Arnedo, Rodrigo

Tipo de recurso:

Fecha de publicación:: 2024

Institución:: Universidad Simón Bolívar

Repositorio:: Repositorio Digital USB

Idioma:: spa